Verici Dx plc announced it has been granted CPT® Proprietary Laboratory Analyses ("PLA") codes1,2 for both its Clarava and Tuteva tests by the American Medical Association ("AMA"). The new codes have been approved and published by the AMA Editorial Panel and are scheduled to become effective on April 1, 2022.